PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 266 filers reported holding PACIRA PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 1.94 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $4,253,702 | -26.5% | 110,171 | +1.2% | 0.08% | -29.1% |
| Q3 2022 | $5,789,000 | +160.2% | 108,837 | +185.2% | 0.11% | +80.3% |
| Q2 2022 | $2,225,000 | -78.4% | 38,159 | -71.7% | 0.06% | -77.8% |
| Q1 2022 | $10,305,000 | +48.8% | 135,027 | +17.3% | 0.28% | +27.9% |
| Q4 2021 | $6,925,000 | +36.2% | 115,097 | +26.8% | 0.22% | +49.3% |
| Q3 2021 | $5,084,000 | -11.3% | 90,782 | -3.9% | 0.14% | -26.2% |
| Q2 2021 | $5,729,000 | +102.5% | 94,418 | +133.9% | 0.20% | +18.9% |
| Q1 2021 | $2,829,000 | +5.7% | 40,362 | -9.8% | 0.16% | -8.4% |
| Q4 2020 | $2,677,000 | +589.9% | 44,742 | +286.4% | 0.18% | +108.1% |
| Q1 2020 | $388,000 | -61.2% | 11,580 | -47.6% | 0.09% | +32.3% |
| Q4 2019 | $1,001,000 | +117.6% | 22,100 | +109.0% | 0.06% | +30.0% |
| Q2 2019 | $460,000 | -60.2% | 10,576 | -55.0% | 0.05% | -90.7% |
| Q3 2018 | $1,155,000 | – | 23,500 | – | 0.54% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Key Colony Management, LLC | 134,600 | $13,045,000 | 11.31% |
| Biondo Investment Advisors, LLC | 279,717 | $27,110,000 | 8.33% |
| GILDER GAGNON HOWE & CO LLC | 3,177,130 | $307,927,000 | 4.48% |
| DARUMA CAPITAL MANAGEMENT LLC | 814,470 | $78,938,000 | 3.47% |
| MAGEE THOMSON INVESTMENT PARTNERS LLC | 126,022 | $12,214,000 | 3.01% |
| NEXT CENTURY GROWTH INVESTORS LLC | 768,396 | $74,472,000 | 2.63% |
| MARXE AUSTIN W & GREENHOUSE DAVID M | 180,000 | $17,446,000 | 2.38% |
| Lisanti Capital Growth, LLC | 48,280 | $4,679,000 | 2.35% |
| INSIGHT CAPITAL RESEARCH & MANAGEMENT INC | 79,017 | $7,658,000 | 2.00% |
| Atika Capital Management LLC | 21,500 | $2,084,000 | 1.60% |